EUTYLIA VAGINAL DOUCHE IS A MEDICAL DEVICE WITH SANITIZING, SOOTHING AND DECONGESTANT ACTION.

In case of:

• Smelly leucorrhea
• Genital inflammation

• Intimate itching • Vaginal dryness

• For a deeper intimate hygiene (after the menstrual period, after childbirth, after gynecological interventions)

Vaginal irrigation can be done several times a day. It is preferable to apply EuTylia Vaginal Douche before going to sleep.

The most common risk factors for intimate irritation are:

– reduction of vaginal pH
– lack of estrogen
– recurrent infections by germs (mycotic, bacterial or viral) – prolonged antibiotic therapies
– psychosomatic stress

Active Principles

Aqua
Sodium Benzoate Potassium sorbate
Glycerin
Boric Acid
Aloe Barbadensis Leaf Juice Lactic Acid
Chlorhecidine Digluconate Polysorbate 20
Melaleuca Alternifolia Oil Parfum

Boric acid is a weak acid but very well known and appreciated above all for its antibacterial and antifungal properties.
Lactic acid is an organic acid belonging to the alpha hydroxy acid family. Unlike what its name suggests, it does not derive from milk, but from fermentation operated by bacteria (lactic) on molasses. It has moisturizing and exfoliating properties and is a powerful regulator for the skin hydrolipic balance.
The beneficial and healing properties of aloe vera have been known since ancient times. It has excellent moisturizers, repairers and emollients properties.

Eutylia Vaginal Douche is a medical device with a sanitizing, soothing and decongestant action. EuTylia Vaginal douche guarantees a protective action on the vaginal mucous thanks to its specific filmogenic and reparative properties that help restore the vaginal microbiota counteracting the attack of pathogenic microorganisms. It is indicated as adjuvant in the treatment and prevention of vaginitis and bacterial vaginosis, from infections of Candida and as a protective / soothing agent in irritative states of the vaginal mucosa.
EuTylia Vaginal Douche is a medical device containing boric acid , lactic acid and aloe created to restore vaginal physiological conditions (vaginal microbiota and pH rebalancing), which may be altered as a consequence of infections (cervicitis, vaginitis, vaginosis), prolonged antibiotic treatments or menopausal dryness.
EuTylia Vaginal Douche protects the integrity of the vaginal mucosa by making it more resistant to attacks by external pathogenic germs, it favors the physiological repair process of lesions of the mucous membranes (after sexual intercourse, in case of prolonged use of contraceptives, after invasive gynecological tests or gynecological interventions) and contrasts the annoying genital symptoms due to estrogen deficiency.
EuTylia Vaginal Douche has a formulation designed to ensure a deeper intimate hygiene leaving a pleasant and delicate fragrance and a freshness and clean feeling . It is useful in cases of vaginal dryness, as an adjuvant in the treatment of irritations, infections and intimate itching. Thanks to its soft and flexible cannula it can be used easily in any stage of a woman’s life. In order to minimize the risk of allergic or irritative phenomena, it does not contain dyes, non-greasy and does not stain.

1)Hill GB (1993) The microbiology of bacterial vaginosis. Am J Obstet Gynecol 169:450-454 2. Culhane JF, Rauh V, McCollum KF, Hogan VK, Agnew K, Wadhwa PD (2001)
2) The association of psychosocial stress and bacterial vaginosis in a longitudinal cohort. Am J Obstet Gynecol 194(2):381-386 4. Petersen EE, Magnani P (2004)

3) Bacterial vaginosis. Prim Care Update Obgyns 7(5):181-185
4) SOGC Committee Opinion Bacterial vaginosis (1997). SOGC Clinical Practice Guidelines
5) Guaschino S. Benvenuti C. SOPHY Study Group
SOPHY Project: an observational study of vaginal pH and lifestyle in women of different ages and in different physiopathological conditions. Part I.
Minerva Ginecol. Apr; 60 (2): 105-14; 2008
6) Guaschino S. Benvenuti C. SOPHY Study Group
SOPHY project: an observational study of vaginal pH, lifestyle and correct intimate hygiene in women of different ages and in different physiopathological conditions. Part II.
Minerva Ginecol. Oct; 60 (5): 353-62. 2008